MarketResearch.com logo

Recent Blood Diseases Research for October 2014


PharmaPoint: Hemophilia A and B - UK Drug Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Regions: United Kingdom
PharmaPoint: Hemophilia A and B - Japan Drug Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Regions: Japan
PharmaPoint: Hemophilia A and B - Argentina Drug Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Regions: Argentina
PharmaPoint: Hemophilia A and B - China Drug Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Regions: China
Global Hemophilia Market 2014-2018
Topics: Blood Diseases, Research & Development, Drug Discovery
Regions: Global
2014 U.S. Patient care - Blood diseases sold through Offices of physicians-Product & Services Report
Topics: Blood Diseases, Physicians' Offices, Diseases & Conditions
Regions: United States
2014 U.S. Patient care - Blood diseases sold through Medical & surgical hospitals-Product & Services Report
Topics: Blood Diseases, Hospitals & Clinics
Regions: United States
PharmaPoint: Hemophilia A and B - Current and Future Players
Topics: Blood Diseases, Research & Development
Blood Coagulation - Pipeline Review, H2 2013
Topics: Blood Diseases, Coagulation, Drug Discovery
Advate (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases
Kogenate FS (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases
Xyntha (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases
Recombinate (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases
NovoEight (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
CSL-654 (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
N9-GP (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
EpiCast Report: Hemophilia - Epidemiology Forecast to 2022
Topics: Blood Diseases, Manufacturing, Packaging & Detailing
Alprolix (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Bleeding Disorders: World Pharmaceutical Industry and Market 2014-2024
Topics: Blood Diseases, Drug Discovery
Regions: Global
PharmaPoint: Hemophilia A and B - France Drug Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Regions: France
PharmaPoint: Hemophilia A and B - Spain Drug Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Regions: Spain
BeneFix (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases
Rixubis (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Novoseven RT (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Eloctate (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
BAY 94-9027 (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
N8-GP (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
BAX-817 (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2014
Topics: Blood Diseases, Clinical Trial
Regions: Global
IB1001 (Hemophilia A and B) - Forecast and Market Analysis to 2022
Topics: Blood Diseases, Drug Discovery
Therapeutic Class Report Overview - Hemophilia
Topics: Blood Diseases, Drug Discovery
Physician Views: How do European cardiologists perceive oral anticoagulants versus warfarin? – Is Eliquis, Pradaxa or Xarelto their favoured option?
Topics: Blood Diseases, Physicians' Offices, Prescription Drugs
Regions: Europe
Von Willebrand Disease Global Clinical Trials Review, H2, 2013
Topics: Blood Diseases, Drug Discovery, Clinical Trial
Regions: Global
Hemophilia Global Clinical Trials Review, H2, 2013
Topics: Blood Diseases, Clinical Trial
Regions: Global
Intravenous (IV) Iron Drugs
Topics: Blood Diseases, Needles, Syringes, IV Access
Regions: Global


Prev  | 1  | 2  | Next

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.